Skip to main content
. 2017 Dec 21;62(1):e00596-17. doi: 10.1128/AAC.00596-17

FIG 3.

FIG 3

Time to new infections: survival analysis. A Kaplan-Meyer curve shows the cumulative risk of developing new infections in infants (ITT population) treated with either a dispersible- or a crushed-tablet formulation during a 42-day follow-up period.